Prostate-Specific Antigen (PSA) Screening for Prostate Cancer Revisiting the Evidence

被引：19
|
作者：
Carter, H. Ballentine [1 ,2 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, James Buchanan Brady Urol Inst, Baltimore, MD USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2018年 / 319卷 / 18期
关键词：
SERVICES TASK-FORCE; QUALITY-OF-LIFE; METASTATIC-DISEASE; MORTALITY; TRIAL; RISK; MEN; ASSOCIATION; DIAGNOSIS; OUTCOMES;
D O I：
10.1001/jama.2018.4914
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1866 / 1868
页数：3
相关论文
共 50 条
  • [21] Update on screening for prostate cancer with prostate-specific antigen
    Schmid, HP
    Riesen, W
    Prikler, L
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2004, 50 (01) : 71 - 78
  • [22] The Role of Prostate-Specific Antigen in Prostate Cancer Screening
    Constantin, Traian Vasile
    Madan, Victor Lucian
    Constantin, Maria-Magdalena
    Morariu, Silviu-Horia
    Braticevici, Bogdan
    REVISTA ROMANA DE MEDICINA DE LABORATOR, 2014, 22 (02): : 275 - 281
  • [23] Screening for prostate cancer using prostate-specific antigen (PSA) A commentary on a systematic review and meta-analysis
    Borkowetz, A.
    UROLOGE, 2019, 58 (08): : 925 - 928
  • [24] Prostate cancer and prostate specific antigen (PSA) screening in Austria
    Vutuc, C
    Schernhammer, ES
    Haidinger, G
    Waldhör, T
    WIENER KLINISCHE WOCHENSCHRIFT, 2005, 117 (13-14) : 457 - 461
  • [25] Prostate-specific antigen: does the current evidence support its use in prostate cancer screening?
    Duffy, Michael J.
    ANNALS OF CLINICAL BIOCHEMISTRY, 2011, 48 : 310 - 316
  • [26] Critical Appraisal of Prostate-specific Antigen in Prostate Cancer Screening: 20 Years Later
    Pienta, Kenneth J.
    UROLOGY, 2009, 73 (5A) : 11 - 20
  • [27] Prostate-Specific Antigen Screening Trials and Prostate Cancer Deaths: The Androgen Deprivation Connection
    Haines, Ian E.
    Miklos, George L. Gabor
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (20): : 1534 - 1539
  • [28] Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen
    Vickers, Andrew J.
    Sjoberg, Daniel D.
    Ulmert, David
    Vertosick, Emily
    Roobol, Monique J.
    Thompson, Ian
    Heijnsdijk, Eveline A. M.
    De Koning, Harry
    Atoria-Swartz, Coral
    Scardino, Peter T.
    Lilja, Hans
    BMC MEDICINE, 2014, 12
  • [29] Prostate-specific antigen (PSA) velocity: a test of controversial benefit in the era of increased prostate cancer screening
    Borofsky, Michael S.
    Makarov, Danil V.
    ASIAN JOURNAL OF ANDROLOGY, 2011, 13 (04) : 614 - 615
  • [30] Optimal prostate-specific antigen screening interval for prostate cancer
    Kobayashi, D.
    Takahashi, O.
    Fukui, T.
    Glasziou, P. P.
    ANNALS OF ONCOLOGY, 2012, 23 (05) : 1250 - 1253
12345